Leslie Kalman, MD
NPI 1609165992 · General Practice Physician · Glendale, CA
Enrolled with Medicare as Practitioner - General Practice · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1609165992
- Entity type
- Individual
- Primary specialty
- General Practice PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- G21059 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
15 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
9,540 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Complete Ultrasound Scan of Joint76881 | 2,100 | $53 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,102 | $92 |
| Complete Ultrasound of Abdomen and Pelvis Artery and Vein Blood Flow93975 | 896 | $269 |
| Complete Ultrasound Scan Behind Abdominal Cavity76770 | 749 | $114 |
| Complete Ultrasound Scan of Abdomen76700 | 480 | $122 |
| Ultrasound Study of Arm Or Leg Veins With Compression and Maneuvers93970 | 332 | $161 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Dutasteride | 15 |
| Furosemide | 14 |
| Potassium Chloride | 14 |
| Baclofen | 12 |
| Dihydroergotamine Mesylate | 12 |
| Metformin Hcl | 12 |
| Omeprazole/Sodium Bicarbonatebrand: Omeprazole-Sodium Bicarbonate | 12 |
| Olmesartan/Hydrochlorothiazidebrand: Benicar Hct | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-04-07
- Last updated
- 2011-04-07
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.